Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
September 6, 2017
Catalyst Biosciences Announces Positive Factor IX Clinical Data
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), today announced positive clinical data from the first Cohort of its ...
September 6, 2017
Arena Pharmaceuticals to Present Additional Pre-Clinical Data on Ralinepag for Treatment of Pulmonary Arterial Hypertension at International Congress of the European Respiratory Society
SAN DIEGO, Sept. 6, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) will present additional detailed pre-clinical pharmacology and pharmacokinetic data on ralinepag (APD811), the Company's next-generation, ...
September 6, 2017
UroGen Pharma Strengthens Management Team with the Appointment of Paul Chu as Vice President of Business Development
RA'ANANA, Israel, and NEW YORK, Sept. 06, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
September 6, 2017
Rexahn Pharmaceuticals to Present at 19th Annual Rodman & Renshaw Global Investment Conference
ROCKVILLE, Md., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, ...
September 6, 2017
Mateon Therapeutics to Present at the 19th Annual Rodman and Renshaw Global Investment Conference on September 12, 2017
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (MATN), a biopharmaceutical company developing vascular disrupting agents for the treatment of ...
September 6, 2017
DelMar Pharmaceuticals to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 10-12, 2017
VANCOUVER, British Columbia and MENLO PARK, Calif., Sept. 6, 2017 /PRNewswire/ -- DelMar Pharmaceuticals (DMPI) ("DelMar" and "the Company"), a biopharmaceutical company focused on the development ...
September 6, 2017
Sitravatinib Data To Be Highlighted At The IASLC 18th World Conference on Lung Cancer
Mirati Therapeutics, Inc. (MRTX), a clinical stage targeted oncology biotechnology company, will highlight data on sitravatinib at the IASLC 18th World Conference on Lung Cancer ...
September 6, 2017
Molecular Templates to Present at the BioCentury 24th Annual Newsmakers in the Biotech Industry Conference
AUSTIN, Texas, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered ...
September 6, 2017
LifeSci Advisors Announces 10th Board Appointment Through Board Placement Initiative
NEW YORK, Sept. 06, 2017 (GLOBE NEWSWIRE) --  LifeSci Advisors, an investor relations and corporate communications firm focused on the life sciences sector, announced today ...
September 5, 2017
Soleno Therapeutics Announces CFO Transition
REDWOOD CITY, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
September 5, 2017
Kiadis Pharma Appoints Karl Hård as Head of Investor Relations and Communications
Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative products to make bone marrow ...
September 5, 2017
Aradigm Announces Upcoming Data Presentations in Non-Cystic Fibrosis Bronchiectasis at the European Respiratory Society (ERS) 2017 Annual Congress
HAYWARD, Calif. -- (BUSINESS WIRE) -- Aradigm Corporation (ARDM) (the “Company”) today announced the upcoming presentation of research at the European Respiratory Society (ERS) 2017 Annual ...
September 5, 2017
Minerva Neurosciences Announces Enrollment of First Patient in Phase 2b Trial of Seltorexant (MIN-202) as Adjunctive Therapy in Patients With Major Depressive Disorder
WALTHAM, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
September 5, 2017
Eiger Announces FDA Orphan Drug Designation Granted for Pegylated Interferon Lambda in Hepatitis Delta Virus Infection
PALO ALTO, Calif., Sept. 5, 2017 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, today announced ...
September 5, 2017
Lipocine to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
SALT LAKE CITY, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, announced today that Dr. Mahesh Patel, Chairman, President and ...
September 5, 2017
Albireo to Present at 19th Annual Rodman & Renshaw Global Investment Conference
BOSTON, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
September 5, 2017
CytoSorbents Highlights Important Research Advances in Traumatic Brain Injury, Hemorrhagic Shock, and Severe Hyperkalemia at the Military Health System Research Symposium
MONMOUTH JUNCTION, N.J., Sept. 5, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to prevent or treat deadly ...
September 5, 2017
Bellerophon Announces Positive Top Line Phase 2 Data of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
WARREN, N.J., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH), a clinical-stage biotherapeutics company, today announced positive top line data from a Phase 2 ...
September 5, 2017
Aptose Biosciences to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
SAN DIEGO and TORONTO, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (APTO) (APS.TO), a clinical-stage company developing highly differentiated therapeutics that target the ...
September 5, 2017
UroGen Pharma to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
RA'ANANA, Israel, and NEW YORK, Sept. 05, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
Page 131 of 153